ClinicalTrials.gg
RecruitingNCT07214415Updated Oct 9, 2025

Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy

A Phase 2 interventional study of Hyperbaric Oxygen Therapy in TBI Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder and Post Concussive Syndrome, sponsored by Summit Hyperbarics and Wellness. Recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-10-09.

Primary conditionPost-Concussion SyndromeRegistry: Brain Injuries, TraumaticReclassifiedWhy we changed it
Registry
Brain Injuries, Traumatic — the first condition term the registry derived for this study.
ClinicalTrials.gg
Post-Concussion Syndrome
Why
  1. The study's listed conditions name Post-Concussion Syndrome, a narrower term within Brain Injuries, Traumatic.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Summit Hyperbarics and Wellness · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
54
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 77 studies in Post-Concussion Syndrome with a site in United States — 15 open to participants now, 20 under way, 1 of them phase 3. Post-Concussion Syndrome · United States.

Planned enrollment
26th of 61
54 · median 40
Started
2025
with 2 others
Phase 2
14 of 77
5 open now
Primary completion
2026-09
later than 5 of 19 live
Registered
69th of 77
by date
Lead sponsor
4 of 77
Summit Hyperbarics and Wellness

Among the 77 studies in Post-Concussion Syndrome with a site in United States, this one is the 26th largest by planned enrollment of the 61 interventional ones that give a count, is one of 3 that started in 2025, is one of 14 in phase 2, reaches primary completion later than 5 of the 19 other live ones, and was the 69th registered.

Post-Concussion Syndrome

140 studies on the registry are indexed under Post-Concussion Syndrome; 33 are open to participants now.

Browse Post-Concussion Syndrome studies →

Open to participants now

15 of the 77 studies in Post-Concussion Syndrome with a site in United States are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 24 Post-Concussion Syndrome studies recruiting now, 3 (13%) set no upper age limit and 20 (83%) stop at 75 or younger; 2 take children under 18; 5 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 77 studies in Post-Concussion Syndrome with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate how hyperbaric oxygen therapy (HBOT) may affect cognitive functioning, post-traumatic stress disorder (PTSD), depression, anxiety, and overall quality of life in veterans.

  1. Does Hyperbaric Oxygen Therapy improve cognitive functioning, psychological well-being, and quality of life among veterans, as measured by pre-and post-treatment scores?
  2. To what extent does Hyperbaric Oxygen Therapy improve cognitive functioning, psychological well-being, and qualify of life among veterans, after controlling for demographic characteristics.
03

Conditions studied

  • TBI Traumatic Brain Injury
  • PTSD - Post Traumatic Stress Disorder
  • Post Concussive Syndrome

Browse trials for

04

In context

Post-Concussion Syndrome Reclassified

140 studies on the registry are indexed under Post-Concussion Syndrome; 33 are open to participants now.

This study's planned enrollment of 54 is close to the median of 52 across 113 interventional studies indexed under Post-Concussion Syndrome.

Browse Post-Concussion Syndrome studies →

Lead sponsor

Summit Hyperbarics and Wellness is the lead sponsor of 4 studies on the registry; 4 are open to participants now.

Compared within Post-Concussion Syndrome, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Brain Injuries, Traumatic. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. At least 18 years of age.
  2. Veteran status
  3. Clinically diagnosed with a mTBI, PTSD, Anxiety, or Depression disorder by meeting the , Fifth Edition, and by a qualified and trained professional.
  4. The subject is willing and able to read, understand, and sign an . Additionally, the subject has clear consciousness and the ability to express self-feelings independently.
  5. Exposed to at least one trauma-focused therapy or evidence-based psychotherapeutic treatment, such as prolonged exposure therapy, EMDR, or CBT, to name a few.
  6. Completed cognitive and psychological measurements.
  7. Clinical diagnoses cause significant impairment in social or occupational functioning or some other functional capacity.
  8. Sexually active female participants of and sexually active male participants with female partners of childbearing potential must agree to use an acceptable method of for the duration of the study and for 30 days following the final HBOT session.
  9. Stability on any current psychoactive medications (antidepressants, anti-anxiety medications, antipsychotics, stimulants, and mood stabilizers).

Exclusion criteria

Exclusion Criteria:

  1. Untreated pneumothorax
  2. History of spontaneous pneumothorax
  3. Severe sinus infection
  4. Upper respiratory infection
  5. Asymptomatic pulmonary lesions on chest x-ray
  6. Uncontrollable high fever (greater than 39C)
  7. History of chest or ear surgery
  8. Congenital spherocytosis
  9. Any anemia or blood disorder
  10. Any convulsive disorder
  11. History of optic neuritis or sudden blindness
  12. Middle ear infection
  13. Diabetes mellitus (insulin therapy)
  14. The subject is pregnant or lactating
  15. Nicotine use/substance use/addiction
  16. Acute Hypoglycemia
  17. Diagnosed (COPD) and Emphysema
  18. Presenting with symptoms of cough, congestion, vomiting, diarrhea, or open wounds.
  19. Active
  20. Current manic, delusional, or psychotic episodes
  21. Serious/current suicidal ideations
  22. Severe or unstable physical disorders or major cognitive deficits
  23. Inability to attend scheduled clinic visits or comply with study protocols.
  24. Treated with HBOT for any reason prior to study enrollment.
  25. Non-English speakers
  26. History of retinal repair, including laser photocoagulation or retinal detachment surgery.
  27. History of middle ear surgery, including tympanoplasty, mastoidectomy, or pressure equalization tube placement.
  28. Age greater than 75 years.
  29. Use of any of the following medications during the study period: Anti-metabolites (e.g., methotrexate, azathioprine); Chemotherapuetic agents (e.g., cyclophosphamide, cisplatin); Mafenide acetate e.g., Sulfamylon); Disulfiram (e.g, Antabuse); Peripheral vasodilators known to interact with oxygen exposure (e.g., nitroglycerin); and Antibacterial drugs with known HBOT interaction risks.
Terms in these criteria, in plain language(6)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

06

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
54 participants (estimated)

Study arms

  • Experimental
    HBOT Intervention Group

    Drug: Hyperbaric Oxygen Therapy

Interventions

  • DrugHyperbaric Oxygen Therapy

    Each HBOT session is scheduled for approximately 95 minutes. The session will begin with a descent of up to 15 minutes (longer if needed for comfort/safety) to a pressure of 2.0 ATA, followed by 30 minutes of breathing 100% oxygen. At the midpoint, there will be a 5-minute air break from oxygen, after which subjects resume breathing 100% oxygen for another 30 minutes. Finally, the session will conclude with an ascent of up to 15 minutes (longer if needed for comfort/safety) back to 1.0 ATA. All sessions are delivered under direct medical supervision with standardized safety protocols. Once approved after medical and behavioral screening, participants complete a battery of cognitive, mental health, and quality of life assessments at baseline (pre-) and after completing the therapy (post-). This arm is distinct from any sham or control interventions because all participants receive the active HBOT treatment.

07

What researchers measure

Primary outcomes

  1. PTSD Checklist for DSM-5 (PCL-5)

    Self-report questionnaire to assess symptoms of PTSD

    Time frame: From baseline assessment prior to first HBOT session to immediately after completion of final HBOT session

  2. NeuroTrax

    A computerized cognitive test to measure various cognitive functions, including memory, executive functioning, visual-spatial perception, verbal function, attention, information processing speed, and motor skills.

    Time frame: From baseline assessment prior to first HBOT session to immediately after completion of final HBOT session.

  3. Patient Health Questionnaire-9 (PHQ-9)

    Self-report questionnaire to assess depression severity

    Time frame: From baseline assessment prior to first HBOT session to immediately after completion of final HBOT session

  4. Generalized Anxiety Disorder 7-item scale (GAD-7)

    Self-report questionnaire to measure anxiety severity

    Time frame: From baseline assessment prior to first HBOT session to immediately after completion of final HBOT session

  5. World Health Organization Quality of Life (WHOQOL-BREF)

    Self-report questionnaire to rate a person's perception of his/her position in their life in the context of physical, psychological, level of independence, social relationships, environment, and spirituality/religion/personal belief domains and facets

    Time frame: From baseline assessment prior to first HBOT session to immediately after completion of final HBOT session

08

Study locations

1 of 1 sites recruiting
09

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2025 (actual). Primary completion is estimated for Sep 2026, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2025
First posted
Oct 9, 2025
StartActual
Oct 1, 2025
Primary completionEst.
Sep 15, 2026
CompletionEst.
Sep 15, 2026
Last update
Oct 9, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07214415
Lead sponsor
Summit Hyperbarics and Wellness
Responsible party
Steve Wyman (Medical Director, Summit Hyperbarics and Wellness) — Principal investigator
First posted
Oct 9, 2025
Start date
Oct 1, 2025
Primary completion
Sep 15, 2026 (estimated)
Completion
Sep 15, 2026 (estimated)
Last update
Oct 9, 2025

Study contacts

Troy Nickel, PhD
Contact
tnickel@shwidaho.org
208-813-9541
Steven Wyman, MD
principal investigator · Summit Hyperbarics and Wellness

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion